Literature DB >> 21053052

Computer-aided drug design platform using PyMOL.

Markus A Lill1, Matthew L Danielson.   

Abstract

The understanding and optimization of protein-ligand interactions are instrumental to medicinal chemists investigating potential drug candidates. Over the past couple of decades, many powerful standalone tools for computer-aided drug discovery have been developed in academia providing insight into protein-ligand interactions. As programs are developed by various research groups, a consistent user-friendly graphical working environment combining computational techniques such as docking, scoring, molecular dynamics simulations, and free energy calculations is needed. Utilizing PyMOL we have developed such a graphical user interface incorporating individual academic packages designed for protein preparation (AMBER package and Reduce), molecular mechanics applications (AMBER package), and docking and scoring (AutoDock Vina and SLIDE). In addition to amassing several computational tools under one interface, the computational platform also provides a user-friendly combination of different programs. For example, utilizing a molecular dynamics (MD) simulation performed with AMBER as input for ensemble docking with AutoDock Vina. The overarching goal of this work was to provide a computational platform that facilitates medicinal chemists, many who are not experts in computational methodologies, to utilize several common computational techniques germane to drug discovery. Furthermore, our software is open source and is aimed to initiate collaborative efforts among computational researchers to combine other open source computational methods under a single, easily understandable graphical user interface.

Entities:  

Mesh:

Year:  2010        PMID: 21053052     DOI: 10.1007/s10822-010-9395-8

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  31 in total

Review 1.  Exploring expression data: identification and analysis of coexpressed genes.

Authors:  L J Heyer; S Kruglyak; S Yooseph
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

2.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 3.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.

Authors:  F Ooms
Journal:  Curr Med Chem       Date:  2000-02       Impact factor: 4.530

Review 4.  High-throughput docking as a source of novel drug leads.

Authors:  Juan C Alvarez
Journal:  Curr Opin Chem Biol       Date:  2004-08       Impact factor: 8.822

5.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

6.  Rescoring docking hit lists for model cavity sites: predictions and experimental testing.

Authors:  Alan P Graves; Devleena M Shivakumar; Sarah E Boyce; Matthew P Jacobson; David A Case; Brian K Shoichet
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

7.  New computational method for prediction of interacting protein loop regions.

Authors:  Matthew L Danielson; Markus A Lill
Journal:  Proteins       Date:  2010-05-15

8.  Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking.

Authors:  Jozef Hritz; Anita de Ruiter; Chris Oostenbrink
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

9.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

10.  The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data.

Authors:  Helen Berman; Kim Henrick; Haruki Nakamura; John L Markley
Journal:  Nucleic Acids Res       Date:  2006-11-16       Impact factor: 16.971

View more
  92 in total

1.  Bioinformatic and mutational analysis of channelrhodopsin-2 protein cation-conducting pathway.

Authors:  Anna Pia Plazzo; Nicola De Franceschi; Francesca Da Broi; Francesco Zonta; Maria Federica Sanasi; Francesco Filippini; Marco Mongillo
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

2.  Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery-a structure-based approach.

Authors:  Vishwanath Ramatenki; Ramakrishna Dumpati; Rajender Vadija; Santhiprada Vellanki; Sarita Rajender Potlapally; Rohini Rondla; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-12-24

3.  VSDMIP 1.5: an automated structure- and ligand-based virtual screening platform with a PyMOL graphical user interface.

Authors:  Álvaro Cortés Cabrera; Rubén Gil-Redondo; Almudena Perona; Federico Gago; Antonio Morreale
Journal:  J Comput Aided Mol Des       Date:  2011-08-09       Impact factor: 3.686

4.  DockingApp: a user friendly interface for facilitated docking simulations with AutoDock Vina.

Authors:  Elena Di Muzio; Daniele Toti; Fabio Polticelli
Journal:  J Comput Aided Mol Des       Date:  2017-01-06       Impact factor: 3.686

5.  Simplifying and enhancing the use of PyMOL with horizontal scripts.

Authors:  Blaine H M Mooers
Journal:  Protein Sci       Date:  2016-08-16       Impact factor: 6.725

6.  Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures.

Authors:  Matthew L Danielson; Prashant V Desai; Michael A Mohutsky; Steven A Wrighton; Markus A Lill
Journal:  Eur J Med Chem       Date:  2011-06-23       Impact factor: 6.514

7.  Integrative X-ray Structure and Molecular Modeling for the Rationalization of Procaspase-8 Inhibitor Potency and Selectivity.

Authors:  Janice H Xu; Jerome Eberhardt; Brianna Hill-Payne; Gonzalo E González-Páez; José Omar Castellón; Benjamin F Cravatt; Stefano Forli; Dennis W Wolan; Keriann M Backus
Journal:  ACS Chem Biol       Date:  2020-01-23       Impact factor: 5.100

8.  Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36.

Authors:  Peng Wei; Fu-de Sun; Li-Min Zuo; Jing Qu; Peng Chen; Li-da Xu; Shi-Zhong Luo
Journal:  J Biol Chem       Date:  2017-03-23       Impact factor: 5.157

9.  Significant enhancement of docking sensitivity using implicit ligand sampling.

Authors:  Mengang Xu; Markus A Lill
Journal:  J Chem Inf Model       Date:  2011-03-04       Impact factor: 4.956

10.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.